Priority Date: 12.12.11 (US 201161569609P)

TRANSDERMAL DELIVERY SYSTEM COMPRISING BUPRENORPHINE

  • Application ID: EP12826670
  • Status: The patent has been granted

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 51 - 200 employees
Company dna maiwald patentanwalts gmbh
operating since 1995
Headquarter in Munich and 4 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 12.12.2011 - Priority Date (US 201161569609P)
  • 20.06.2013 - Publication A1 (WO2013088254)
  • 22.10.2014 - Publication A1 (EP2790685)
  • 16.08.2017 - Publication B1 (EP2790685)

IPC Classification